Webinar | June 7, 2021

Innovation: Shortening The Path To Commercialization In Advanced Therapies

Source: Precision ADVANCE

In this panel sponsored by Precision ADVANCE, Clare Sarvary Fourrier, SVP of Operational Strategy (EU) for Precision for Medicine moderates a discussion with industry experts to share perspectives on the current state of the cell and gene therapy industry and provide key insights in shortening time-to-market for advanced therapies.

  • Alex Grosvenor SVP, PRECISIONadvisors | Precision Value & Health
  • Dave Lennon President | Novartis Gene Therapies
  • Anshul Mangal President | Project Farma (PF) & Precision ADVANCE
  • Parag V. Meswani Chief Commercial Officer | Sio Gene Therapies
  • Pascal Touchon President & CEO | Atara Biotherapeutics
access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

Precision ADVANCE